来源|凤凰网财经《公司研究院》 当元旦节日氛围正浓，中国汽车行业却迎来一场无声的战役。 各大汽车公司相继于 1月初公布2025年最后一个月的销量成绩，全年终局榜单也随之揭晓。这张成绩单揭开行业现实，传统巨头正在以前所未有的速 度扩张版图，而造车新势力阵营却正在经历残酷的座次洗牌。 新能源转型的洪流中，有人乘风破浪，也有人黯然退潮。 01 传统巨头阵营鼎立，强者恒强 刚刚过去的 2025年，传统自主品牌巨头表现堪称强势。 比亚迪毫无悬念地继续领跑， 2025年全年累计销量突破460万辆，同比增长接近8%。其中纯电车型全年累计销量225.67万辆，同比大增27.86%。 由此，比亚迪继续斩获中国汽车市场车企、品牌双料销量冠军，以及全球新能源市场销量冠军。 尤其值得注意的是，比亚迪海外市场年销量首次突破百万大关，乘用车及皮卡海外销量达 104.96万辆，同比激增145%。这意味着，中国汽车销冠 正在加速成长为世界级选手。 图片来源：比亚迪汽车 紧跟比亚迪的步伐，吉利汽车在 2025年上演一出追逐大戏。全年累计销量超302万辆，超额完成全年300万辆销售目标，同比激增39%，创下历史 新高。吉利强劲增长的动力来源于其 ...

2026.01. 01 本文字数：1330，阅读时长大约2分钟 作者 | 第一财经 葛慧 随着12月份结束，新势力也交出了2025年的年度成绩单，总体而言，只有零跑、小米和小鹏三个品 牌完成了全年的销量目标。 零跑汽车是2025年新势力最大的"黑马"，全年销量近60万辆，跃升为新势力销冠，年目标达成率超 119%。 华为虽然不造车，但是凭借"五界"的合力，其销售数据近期持续攀。数据显示，鸿蒙智行2025年全 年累计交付589107辆，同比增长32%。 极氪在将领克数据合并统计后，也显示出了规模优势，同样越过了50万辆的关口。但分品牌来看， 极氪全年交付量为22.4万辆，与32万辆的年目标相比，差距近10万辆；领克品牌全年销量35万辆， 与年目标销量39万辆相比也差了4万辆。 | | | 2025年新势力车企TOP10成绩单 | | | | | --- | --- | --- | --- | --- | --- | | 排名 公司 | 全年销量 | | 2025年目标 目标完成度 2024年销量 同比增长 | | | | 1 零胞 | 596. 555 | 50万辆 | 119.31% | 293, 724 | ...

赛力斯在互动平台表示，公司已获得L3测试牌照。 ...

Group 1 - Samsung Electronics announced that its subsidiary Harman International will acquire ZF Group's advanced driver assistance business for €1.5 billion [1] - Harman International is known for its audio products, while ZF Group is a major player in the transmission sector, making this collaboration between two seemingly unrelated industries noteworthy [3] - The acquisition will provide Harman with technologies and products such as forward-looking vehicle cameras and advanced driver assistance system controllers, allowing it to enter the advanced driver assistance systems market [5] Group 2 - Samsung estimates that the market for advanced driver assistance systems will grow from 62.6 trillion Korean won in 2025 to 97.4 trillion Korean won by 2030 [5] - The transaction is expected to be completed by 2026, a critical year as major global manufacturers plan to transition from advanced driver assistance to Level 3 autonomous driving [7] - There are concerns regarding the effectiveness of this acquisition, as both companies lack significant achievements in the driver assistance field [5][7]

Market Overview - On December 22, Hong Kong stocks rose, with the Hang Seng Index up 111 points (0.4%) closing at 25,801 points[1] - The Hang Seng Tech Index increased by 47 points (0.9%) to close at 5,526 points[1] - Daily trading volume decreased to HKD 169.8 billion, with net inflow from southbound funds at HKD 3.13 billion[1] Sector Performance - International gold and silver prices reached new highs, with Zhaojin (1818 HK) up 6.0%, China National Gold (2099 HK) up 7.6%, and China Silver (815 HK) up 5.8%[1] - New consumption stocks performed well, with Mixue Ice Cream (2097 HK) rising 10.1% after opening a store in Los Angeles[1] - China Duty Free Group (1880 HK) surged 15.8% following the official closure of Hainan Island[1] US Market Update - On the US side, the Dow Jones rose 277 points (0.5%) to 48,362 points, while the Nasdaq increased by 121 points (0.5%) to 23,428 points[2] - Tesla's stock rose 1.6% amid positive performance of its Robotaxi compared to Google's Waymo[2] - Nvidia's stock increased by 1.5% as rumors suggest potential chip supply to China pending approval[2] Industry Dynamics - In the automotive sector, stocks like Pony.ai (2026 HK) rose 10.7% due to advancements in L3 autonomous driving technology[3] - In pharmaceuticals, a collaboration between Ginkgo Bioworks (1167 HK) and AstraZeneca (AZN US) was announced, with Ginkgo set to receive an upfront payment of USD 100 million and potential milestone payments up to USD 1.915 billion[3] - Ginkgo's stock fell over 10% as the authorization amount was perceived as lower than expected, indicating a possible sell-off after initial positive sentiment[3]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14% [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% on its debut, and Xidi Zhijia (03881), which fell over 8% [1] - The U.S. Senate passed a revised version of the Biosecurity Act as part of the National Defense Authorization Act for fiscal year 2026, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceuticals-B (02142) saw a nearly 7% increase after signing a business development deal worth over $1 billion with Bristol-Myers Squibb [2] - China Duty Free Group (01880) rebounded nearly 7% after winning bids for two major airport duty-free projects in Shanghai, with market attention on the results of the capital airport bidding [3] - Youjia Innovation (02431) rose over 12% as the large-scale rollout of L3 technology approaches, with the company having preemptively positioned itself for L2 and L4 technologies [4] Group 3 - Nine Dragons Paper (02689) increased by over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [5] - Southern Manganese (01091) rose over 9% due to multiple factors driving the continuous increase in electrolytic manganese prices [6] - Yangtze Optical Fibre and Cable (06869) surged over 10%, with a cumulative increase of over 30% in the past three days, driven by sustained demand for optical fibres and cables from AI [7] Group 4 - Ganwan (09890) increased by over 5% after issuing zero-coupon convertible bonds at a premium, raising HKD 450 million to enhance its "AI + gaming" initiatives [8] - Liqin Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [9] - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [10]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14%. The morning trading volume reached 97.5 billion HKD [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% upon debut, and Xidi Zhijia (03881), which fell over 8% after its listing [1] - The U.S. Senate passed a revised version of the Biodefense Act as part of the National Defense Authorization Act for fiscal year 2026, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceuticals-B (02142) saw a nearly 7% increase after signing a business development deal worth over 1 billion USD with Bristol-Myers Squibb [2] - China Duty Free Group (601888) (01880) rebounded nearly 7% after winning bids for two major duty-free projects at Shanghai airports, with market attention on the results of the Capital Airport tender [2] - Youjia Innovation (02431) surged over 12% as L3 large-scale deployment approaches, with the company having made forward-looking arrangements for L2+ and L4 [2] - Nine Dragons Paper (02689) rose over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [2] Group 3 - South Manganese (01091) increased by over 9% due to multiple factors driving the continuous rise in electrolytic manganese prices [3] Group 4 - Yangtze Optical Fibre (601869) (06869) rose over 10%, with a cumulative increase of over 30% in the past three days, driven by sustained demand for optical fibers and cables from AI [4] Group 5 - Ganwan (09890) increased by over 5% after issuing zero-coupon convertible bonds at a premium, raising 450 million HKD to enhance its "AI + gaming" strategy [5] Group 6 - Liqin Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [6] Group 7 - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [7]

Group 1 - The Hang Seng Index rose by 0.65%, gaining 165 points to close at 25,663 points, while the Hang Seng Tech Index increased by 1.14% [1] - New listings in the Hong Kong stock market included Zhihui Mining (02546), which surged over 110% on its debut, and Xidi Zhijia (03881), which fell over 8% [1] - The U.S. Senate passed a revised version of the Biological Safety Act as part of the 2026 National Defense Authorization Act, leading to a significant rebound in pharmaceutical stocks, with WuXi Biologics (02269) rising over 6% and 3SBio (01530) increasing by 3.7% [1] Group 2 - HAP Pharmaceutical-B (02142) saw a nearly 7% increase after signing a BD deal worth over $1 billion with Bristol-Myers Squibb [2] - China Duty Free Group (01880) rebounded nearly 7% after winning bids for duty-free projects at two major airports in Shanghai, with market attention on the results of the capital airport bidding [3] Group 3 - Youjia Innovation (02431) rose over 12% as L3 large-scale deployment approaches, with the company strategically positioning itself for L2+L4 technologies [4] - Nine Dragons Paper (02689) increased over 3% as the industry leader announced a series of shutdown plans to support price and inventory levels before the Spring Festival [4] Group 4 - Southern Manganese (01091) rose over 9% due to multiple factors driving the continuous increase in electrolytic manganese prices [5] - Changfei Optical Fiber and Cable (06869) surged over 10%, with a cumulative increase of over 30% in the past three days, driven by AI demand for optical fiber and cable [6] - Ganwan (09890) increased over 5% after issuing zero-coupon convertible bonds at a premium, raising HKD 450 million to enhance its "AI + gaming" strategy [7] - Likun Resources (02245) rose over 9% as Indonesia plans to significantly reduce its nickel ore production targets by 2026 [8] - Shenzhou International (02313) fell over 3% as its major client Nike reported a 32% year-on-year decline in net profit for the second fiscal quarter [9]

Core Viewpoint - The autonomous driving industry is experiencing a historic breakthrough, with China poised to become the first country to initiate large-scale trials of Level 3 (L3) autonomous vehicles [1] Group 1: Company Performance - Youjia Innovation (佑驾创新) saw its stock price rise over 13%, reaching HKD 12.74 with a trading volume of HKD 1.28 billion [1] - The company has achieved commercial deployment of Level 4 (L4) autonomous minibuses and logistics scenarios, establishing a foundation for the widespread rollout of L3 technology through a collaborative model of "L4 technology sinking and L2 data rising" [1] Group 2: Market Position and Strategy - Dongwu Securities reported that Youjia Innovation holds over one-third of the commercial vehicle Advanced Driver Assistance Systems (ADAS) market and has successfully expanded into passenger vehicles and joint venture clients [1] - The company's iPilot series (L2+ and above) products are entering a harvest phase, while its L4 autonomous driving business (iRobo) has achieved commercial breakthroughs [1] - The company plans to launch a dedicated logistics brand "Xiaozhu Unmanned Vehicle" in September 2025, aiming for the delivery of 10,000 units by 2026 [1]

Group 1: Market Overview - The market has been reignited by technology stocks, with the Shanghai Composite Index rising by 1.19%, the Shenzhen Component Index by 2.4%, and the ChiNext Index by 3.39% [1] - There is a coexistence of weak index performance and strong structural excitement in the market, indicating a complex investment environment as the year-end approaches [1][6] Group 2: Tesla and SpaceX Developments - Tesla's stock price has rebounded significantly after a 36% drop in the first quarter, reaching a new closing high of $489.88, up 3.1% recently [3] - Elon Musk's wealth has surged, making him the first person in history to surpass $600 billion, currently at $684.2 billion, with projections for SpaceX to reach a valuation of $1.5 trillion upon its IPO [2][3] - The potential for Tesla's full self-driving technology to be commercialized could push its valuation towards $2 trillion, solidifying its position as a global tech leader [2] Group 3: Autonomous Driving Developments - The Chinese Ministry of Industry and Information Technology has issued the first batch of L3 autonomous driving licenses, marking a shift from "technical validation" to "commercial pilot" for autonomous driving in China [5][9] - Companies like Changan and BAIC Blue Valley have received L3-level licenses, indicating a significant advancement in the domestic autonomous driving sector [5][9] - Tesla's progress in Robotaxi technology is influencing the domestic industry, pushing for faster iterations and advancements in autonomous driving technology [9][10] Group 4: Investment Opportunities - The current market environment is characterized by a focus on sectors with "from 0 to 1" technological breakthroughs, particularly in L3 autonomous driving and commercial aerospace [6][8] - Companies like Zhejiang Shibao and BAIC Blue Valley are becoming focal points for investment due to their roles in the L3 project and potential for industry restructuring [10] - The commercial aerospace sector is also gaining attention, with a shift in focus from broad launch capabilities to more specific components that ensure performance and reliability [10]